Transmucular Quadratus Lumborum Block: Potential Quadriceps Muscle Weakness - Trial NCT05023343
Access comprehensive clinical trial information for NCT05023343 through Pure Global AI's free database. This Phase 4 trial is sponsored by Zealand University Hospital and is currently Completed. The study focuses on Neuromuscular Blockade. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zealand University Hospital
Timeline & Enrollment
Phase 4
Oct 02, 2021
Nov 28, 2021
Primary Outcome
Maximum unilateral knee extension strength
Summary
The aim of this study is to examine whether the administration of the TQL block cause motor
 block of the lumbar plexus and thereby quadriceps muscle weakness. The investigators
 hypothesise that the administration of a unilateral TQL block does not cause quadriceps
 muscle weakness compared to a placebo block.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05023343
Non-Device Trial